Chemical Compound Review:
paclitaxel
Synonyms:
TAXOL,, Taxol?, GNF-Pf-2533, AGN-PC-000A63, CHEMBL601767, ...
Markus Joerger,
Jan H. M. Schellens,
Georg Hempel,
Justin Wilkins,
Harry Hollema,
Henk P. Sleeboom,
Mats Karlsson,
Ad H. G. J. Schrijvers,
Hilary Calvert,
Christian Dittrich,
Alwin D. R. Huitema,
Wjf J. F. Van der Vijgh,
Andrea Martoni,
Miguel A. Izquierdo,
Christian Twelves,
Jan B. Vermorken,
Alan V. Boddy,
Regine Féty,
Duncan I. Jodrell,
Nikolas Pavlidis,
Etienne Chatelut,
Dick J. Richel,
Roberto Sorio,
Jos H. Beijnen,
Evangelos Briasoulis,
Brigitte Tranchand,
Elena Strocchi,
Leona Downey,
Robert B. Livingston,
Maria Koehler,
Michael Arbushites,
Lisa Williams,
Angela Santiago,
Roberta Guzman,
Ivonne Villalobos,
Angelo Di Leo,
Michael F. Press,
Shao Chin Lee,
Nigel Sim,
Sanjiv Kumar Yadav,
Marie-Veronique Clement,
Shazib Pervaiz,
Suresh S. Ramalingam,
Douglas M. Potter,
Chandra P. Belani,
Ronald G. Stoller,
David M. Friedland,
Gurkamal S. Chatta,
Rachel P. Sikorski,
Theodore F. Lagattuta,
Scot C. Remick,
Merrill J. Egorin,
S. Percy Ivy,
Ramesh K. Ramanathan,
- Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET. Hsueh, W.A., Kesner, A.L., Gangloff, A., Pegram, M.D., Beryt, M., Czernin, J., Phelps, M.E., Silverman, D.H. J. Nucl. Med. (2006)
- Dominant negative Rac1 attenuates paclitaxel-induced apoptosis in human melanoma cells through upregulation of heat shock protein 27: a functional proteomic analysis. Lee, S.C., Sim, N., Clement, M.V., Yadav, S.K., Pervaiz, S. Proteomics (2007)
- Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. Joerger, M., Huitema, A.D., Richel, D.J., Dittrich, C., Pavlidis, N., Briasoulis, E., Vermorken, J.B., Strocchi, E., Martoni, A., Sorio, R., Sleeboom, H.P., Izquierdo, M.A., Jodrell, D.I., Calvert, H., Boddy, A.V., Hollema, H., Féty, R., Van der Vijgh, W.J., Hempel, G., Chatelut, E., Karlsson, M., Wilkins, J., Tranchand, B., Schrijvers, A.H., Twelves, C., Beijnen, J.H., Schellens, J.H. Clin. Cancer Res. (2007)
- Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Sui, M., Huang, Y., Park, B.H., Davidson, N.E., Fan, W. Cancer Res. (2007)
- Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Catalano, M.G., Poli, R., Pugliese, M., Fortunati, N., Boccuzzi, G. Endocr. Relat. Cancer (2007)
- Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Bauer, J.A., Chakravarthy, A.B., Rosenbluth, J.M., Mi, D., Seeley, E.H., De Matos Granja-Ingram, N., Olivares, M.G., Kelley, M.C., Mayer, I.A., Meszoely, I.M., Means-Powell, J.A., Johnson, K.N., Tsai, C.J., Ayers, G.D., Sanders, M.E., Schneider, R.J., Formenti, S.C., Caprioli, R.M., Pietenpol, J.A. Clin. Cancer Res. (2010)
- Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies. Karapanagiotou, E.M., Roulstone, V., Twigger, K., Ball, M., Tanay, M., Nutting, C., Newbold, K., Gore, M.E., Larkin, J., Syrigos, K.N., Coffey, M., Thompson, B., Mettinger, K., Vile, R.G., Pandha, H.S., Hall, G.D., Melcher, A.A., Chester, J., Harrington, K.J. Clin. Cancer Res. (2012)
- Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy. Leandro-García, L.J., Leskelä, S., Jara, C., Gréen, H., Avall-Lundqvist, E., Wheeler, H.E., Dolan, M.E., Inglada-Perez, L., Maliszewska, A., de Cubas, A.A., Comino-Méndez, I., Mancikova, V., Cascón, A., Robledo, M., Rodríguez-Antona, C. Clin. Cancer Res. (2012)
- Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Wheeler, H.E., Gamazon, E.R., Wing, C., Njiaju, U.O., Njoku, C., Baldwin, R.M., Owzar, K., Jiang, C., Watson, D., Shterev, I., Kubo, M., Zembutsu, H., Winer, E.P., Hudis, C.A., Shulman, L.N., Nakamura, Y., Ratain, M.J., Kroetz, D.L., Cox, N.J., Dolan, M.E. Clin. Cancer Res. (2013)
- A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies. Ramalingam, S.S., Egorin, M.J., Ramanathan, R.K., Remick, S.C., Sikorski, R.P., Lagattuta, T.F., Chatta, G.S., Friedland, D.M., Stoller, R.G., Potter, D.M., Ivy, S.P., Belani, C.P. Clin. Cancer Res. (2008)
- Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases. Yang, H., Cabral, F. J. Biol. Chem. (2007)
- Chromosome 17 polysomy without human epidermal growth factor receptor 2 amplification does not predict response to lapatinib plus paclitaxel compared with paclitaxel in metastatic breast cancer. Downey, L., Livingston, R.B., Koehler, M., Arbushites, M., Williams, L., Santiago, A., Guzman, R., Villalobos, I., Di Leo, A., Press, M.F. Clin. Cancer Res. (2010)
- Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Janssen, K., Pohlmann, S., Jänicke, R.U., Schulze-Osthoff, K., Fischer, U. Blood (2007)
- The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Ahmed, A.A., Mills, A.D., Ibrahim, A.E., Temple, J., Blenkiron, C., Vias, M., Massie, C.E., Iyer, N.G., McGeoch, A., Crawford, R., Nicke, B., Downward, J., Swanton, C., Bell, S.D., Earl, H.M., Laskey, R.A., Caldas, C., Brenton, J.D. Cancer. Cell (2007)
- Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. Cicchillitti, L., Di Michele, M., Urbani, A., Ferlini, C., Donat, M.B., Scambia, G., Rotilio, D. J. Proteome Res. (2009)